The adenosine deaminase gene polymorphism is associated with chronic heart failure risk in chinese

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 15259-15271

  He, Hai Rong ^a   Li, Yuan Jie ^a   He, Gong Hao ^b   Wang, Ya Jun ^a   Zhai, Ya Jing ^a   Xie, Jiao ^a   Zhang, Wei Peng ^a   Dong, Ya Lin ^a   Lu, Jun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

ADA; Adenosine; Chronic heart failure; rs452159; SNP

Indexed keywords

ADA PROTEIN, HUMAN; ADENOSINE DEAMINASE;

AGED; CASE CONTROL STUDY; CHINA; FEMALE; GENETICS; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSINE DEAMINASE; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84906840044     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150915259     Document Type: Article

References (40)

1. Davidson, P.M.; Inglis, S.C.; Newton, P.J. Self-care in patients with chronic heart failure. Expert Rev. Pharm. Outcomes Res. 2013, 13, 351-359.
2. Mohammadzadeh, N.; Safdari, R.; Rahimi, A. Multi-agent system as a new approach to effective chronic heart failure management: Key considerations. Healthc. Inform. Res. 2013, 19, 162-166.
3. Hori, M.; Kitakaze, M. Adenosine, the heart, and coronary circulation. Hypertension 1991, 18, 565-574.
4. Kitakaze, M.; Hori, M.; Takashima, S.; Sato, H.; Inoue, M.; Kamada, T. Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 1993, 87, 208-215.
5. Del, R.S.; Cabiati, M.; Martino, A.; Simioniuc, A.; Morales, M.A.; Picano, E. Adenosine receptor mRNA expression in normal and failing minipig hearts. J. Cardiovasc. Pharmacol. 2011, 58, 149-156.
6. Mallet, R.T.; Lee, S.C.; Downey, H.F. Endogenous adenosine increases O2 utilisation efficiency in isoprenaline-stimulated canine myocardium. Cardiovasc. Res. 1996, 31, 102-116.
7. Sukoyan, G.V.; Gongadze, N.V. Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency. Bull. Exp. Biol. Med. 2011, 150, 610-613.
8. Peart, J.N.; Headrick, J.P. Adenosinergic cardioprotection: Multiple receptors, multiple pathways. Pharmacol. Ther. 2007, 114, 208-221.
9. Belardinelli, L.; Shryock, J.C.; Song, Y.; Wang, D.; Srinivas, M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J. 1995, 9, 359-365.
10. Andreassi, M.G.; Laghi, P.F.; Picano, E.; Capecchi, P.L.; Pompella, G.; Foffa, I.; Borghini, A.; Sicari, R. Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. Pharmacogenet. Genomics 2011, 21, 469-475.
11. Sommerschild, H.T.; Kirkeboen, K.A. Adenosine and cardioprotection during ischaemia and reperfusion-An overview. Acta Anaesthesiol. Scand. 2000, 44, 1038-1055.
12. Mullane, K.; Bullough, D. Harnessing an endogenous cardioprotective mechanism: Cellular sources and sites of action of adenosine. J. Mol. Cell. Cardiol. 1995, 27, 1041-1054.
13. Mubagwa, K.; Mullane, K.; Flameng, W. Role of adenosine in the heart and circulation. Cardiovasc. Res. 1996, 32, 797-813.
14. Willems, L.; Reichelt, M.E.; Molina, J.G.; Sun, C.X.; Chunn, J.L.; Ashton, K.J.; Schnermann, J.; Blackburn, M.R.; Headrick, J.P. Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts. Cardiovasc. Res. 2006, 71, 79-87.
15. Choi, J.W.; Park, C.S.; Hwang, M.; Nam, H.Y.; Chang, H.S.; Park, S.G.; Han, B.G.; Kimm, K.; Kim, H.L.; Oh, B. et al. A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli. J. Allergy Clin. Immunol. 2008, 122, 1119-1126.
16. Howe, K.J.; Ares, M.J. Intron self-complementarity enforces exon inclusion in a yeast pre-mRNA. Proc. Natl. Acad. Sci. USA 1997, 94, 12467-12472.
17. Wang, Z.; Xiao, X.; van Nostrand, E.; Burge, C.B. General and specific functions of exonic splicing silencers in splicing control. Mol. Cell 2006, 23, 61-70.
18. Pohl, M.; Bortfeldt, R.H.; Grutzmann, K.; Schuster, S. Alternative splicing of mutually exclusive exons-A review. Biosystems 2013, 114, 31-38.
19. Napolioni, V.; Predazzi, I.M. Age- and gender-specific association between ADA (22G>A) and TNF-α (-308G>A) genetic polymorphisms. Tissue Antigens 2010, 76, 311-314.
20. Napolioni, V.; Carpi, F.M.; Gianni, P.; Sacco, R.; di Blasio, L.; Mignini, F.; Lucarini, N.; Persico, A.M. Age- and gender-specific epistasis between ADA and TNF-α influences human life-expectancy. Cytokine 2011, 56, 481-488.
21. Dutra, G.P.; Ottoni, G.L.; Lara, D.R.; Bogo, M.R. Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients. Rev. Bras. Psiquiatr. 2010, 32, 275-278.
22. Bachmann, V.; Klaus, F.; Bodenmann, S.; Schafer, N.; Brugger, P.; Huber, S.; Berger, W.; Landolt, H.P. Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans. Cereb. Cortex. 2012, 22, 962-970.
23. Mazzotti, D.R.; Guindalini, C.; de Souza, A.A.; Sato, J.R.; Santos-Silva, R.; Bittencourt, L.R.; Tufik, S. Adenosine deaminase polymorphism affects sleep EEG spectral power in a large epidemiological sample. PLoS One 2012, 7, e44154.
24. Safranow, K.; Rzeuski, R.; Binczak-Kuleta, A.; Czyzycka, E.; Skowronek, J.; Jakubowska, K.; Wojtarowicz, A.; Loniewska, B.; Ciechanowicz, A.; Kornacewicz-Jach, Z. et al. ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology 2007, 108, 275-281.
25. Riksen, N.P.; Franke, B.; van den Broek, P.; Naber, M.; Smits, P.; Rongen, G.A. The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo. Pharmacogenet. Genomics 2008, 18, 843-846.
26. Pangilinan, F.; Molloy, A.M.; Mills, J.L.; Troendle, J.F.; Parle-McDermott, A.; Signore, C.; O'Leary, V.B.; Chines, P.; Seay, J.M.; Geiler-Samerotte, K. et al. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med. Genet. 2012, 13, 62.
27. Gass, N.; Ollila, H.M.; Utge, S.; Partonen, T.; Kronholm, E.; Pirkola, S.; Suhonen, J.; Silander, K.; Porkka-Heiskanen, T.; Paunio, T. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J. Affect. Disord. 2010, 126, 134-139.
28. Asakura, M.; Asanuma, H.; Kim, J.; Liao, Y.; Nakamaru, K.; Fujita, M.; Komamura, K.; Isomura, T.; Furukawa, H.; Tomoike, H. et al. Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens. Res. 2007, 30, 781-787.
29. Fujita, M.; Asakura, M.; Sanada, S.; Funaya, H.; Tsukamoto, O.; Komamura, K.; Asanuma, H.; Taketani, S.; Isomura, T.; Nakamaru, K. et al. Activation of ecto-5'-nucleotidase in the blood and hearts of patients with chronic heart failure. J. Card. Fail. 2008, 14, 426-430.
30. Fredholm, B.B. Effect of adenosine, adenosine analogues and drugs inhibiting adenosine inactivation on lipolysis in rat fat cells. Acta Physiol. Scand. 1978, 102, 191-198.
31. Schwabe, U.; Schonhofer, P.S.; Ebert, R. Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3':5'-monophosphate, lipolysis, and glucose oxidation in isolated fat cells. Eur. J. Biochem. 1974, 46, 537-545.
32. Dowling, H.J.; Fried, S.K.; Pi-Sunyer, F.X. Insulin resistance in adipocytes of obese women: effects of body fat distribution and race. Metabolism 1995, 44, 987-995.
33. Lin, Z.J.; Zhang, B.; Liu, X.Q.; Yang, H.L. Abdominal fat accumulation with hyperuricemia and hypercholesterolemia quail model induced by high fat diet. Chin. Med. Sci. J. 2009, 24, 191-194.
34. Bottini, N.; Gloria-Bottini, F.; Borgiani, P.; Antonacci, E.; Lucarelli, P.; Bottini, E. Type 2 diabetes and the genetics of signal transduction: A study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism 2004, 53, 995-1001.
35. Peculis, R.; Latkovskis, G.; Tarasova, L.; Pirags, V.; Erglis, A.; Klovins, J. A nonsynonymous variant I248L of the adenosine A3 receptor is associated with coronary heart disease in a Latvian population. DNA Cell Biol. 2011, 30, 907-911.
36. International HapMap Project. Available online: http://hapmap.ncbi.nlm.nih.gov/ (accessed on 27 August 2014).
37. He, G.H.; Lu, J.; Shi, P.P.; Xia, W.; Yin, S.J.; Jin, T.B.; Chen, D.D.; Xu, G.L. Polymorphisms of human histamine receptor H4 gene are associated with breast cancer in Chinese Han population. Gene 2013, 519, 260-265.
38. Li, S.; Jin, T.; Zhang, J.; Lou, H.; Yang, B.; Li, Y.; Chen, C.; Zhang, Y. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol. 2012, 36, 283-287.
39. Gabriel, S.; Ziaugra, L.; Tabbaa, D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr. Protoc. Hum. Genet. 2009, 2, 2-12.
40. Thomas, R.K.; Baker, A.C.; Debiasi, R.M.; Winckler, W.; Laframboise, T.; Lin, W.M.; Wang, M.; Feng, W.; Zander, T.; MacConaill, L. et al. High-throughput oncogene mutation profiling in human cancer. Nat. Genet. 2007, 39, 347-351.